Phibro Animal Health PAHC Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Animal Health | $1.16B+34.3% | $1.12B+43.3% | $1.06B+46.0% | $962.8M+36.3% | $861.83M+24.6% | |
| Mineral Nutrition | $269.51M+7.3% | $262.86M+5.7% | $257.17M+4.2% | $253.24M+3.9% | $251.15M+4.6% | |
| Performance Products | $73.4M-5.5% | $77.18M+6.2% | $78.78M+10.0% | $80.18M+18.7% | $77.7M+14.6% | |
| Selling General And Administrative Expense by Business | ||||||
| Mineral Nutrition | $7.64M+2.8% | $7.62M+4.8% | $7.43M+0.5% | $7.64M+5.0% | $7.43M+3.6% | |
| Performance Products | $8.9M+7.8% | $8.79M+8.0% | $8.45M+4.2% | $8.41M+4.5% | $8.26M-15.8% | |
| Adjusted Earnings Before Interest Taxes Depreciation And Amortization by Business | ||||||
| Mineral Nutrition | $21.64M+4.9% | $22.26M+14.0% | $21.6M+24.6% | $20.84M+26.7% | $20.62M+38.3% | |
| Performance Products | $7.69M-27.3% | $8.8M-8.4% | $9.86M+15.5% | $10.55M+37.6% | $10.58M+53.9% | |
| Cost of Goods Sold by Business | ||||||
| Mineral Nutrition | $242.4M+7.5% | $235.12M+6.2% | $230.26M+4.4% | $226.86M+2.0% | $225.39M+1.5% | |
| Performance Products | $57.76M-1.5% | $60.56M+11.1% | $61.5M+11.9% | $62.37M+16.5% | $58.64M+6.5% | |
| D&A by Business | ||||||
| Mineral Nutrition | $2.17M+4.6% | $2.15M-0.3% | $2.12M-7.7% | $2.1M-13.4% | $2.08M-18.9% | |
| Performance Products | $951K-26.8% | $979K-32.7% | $1.03M-35.4% | $1.14M-32.6% | $1.3M-24.6% | |
| Revenue by Product | ||||||
| Medicated Feed Additives And Others | $809.63M+45.5% | $785.48M+62.6% | $733.71M+68.8% | $646.35M+53.5% | $556.53M+36.3% | |
| Mineral Nutrition | $269.51M+7.3% | $262.86M+5.7% | $257.17M+4.2% | $253.24M+3.9% | $251.15M+4.6% | |
| Nutritional Specialties | $192.57M+10.2% | $189.11M+10.2% | $184.79M+10.6% | $179.29M+8.9% | $174.74M+5.0% | |
| Performance Products | $73.4M-5.5% | $77.18M+6.2% | $78.78M+10.0% | $80.18M+18.7% | $77.7M+14.6% | |
| Vaccines | $154.94M+18.7% | $149.7M+15.1% | $145.23M+14.7% | $137.15M+13.5% | $130.57M+11.7% | |
| Revenue by Geography | ||||||
| Asia Pacific | $114.86M+44.8% | $112.4M+64.9% | $112.19M+77.1% | $97.42M+54.1% | $79.3M+23.7% | |
| EMEA | $191.8M+42.0% | $186.24M+44.0% | $174.05M+37.9% | $160.23M+31.4% | $135.03M+10.8% | |
| Latin America And Canada | $334.52M+17.5% | $329.65M+23.2% | $314.72M+21.0% | $298.65M+20.6% | $284.74M+19.9% | |
| US | $858.86M+24.2% | $836.03M+30.4% | $798.72M+33.8% | $739.92M+26.5% | $691.61M+20.0% | |
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization by Geography | ||||||
| BR | $143.93M— | —— | —— | —— | —— | |
| IE | $106.52M— | —— | —— | —— | —— | |
| IL | $306.25M— | —— | —— | —— | —— | |
| US | $949.26M— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Phibro Animal Health break its business down?
- Phibro Animal Health (PAHC) reports revenue by business across 3 parts — Animal Health, Mineral Nutrition and Performance Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Phibro Animal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Phibro Animal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
